Clinical Trial Update: Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*

View source ↗

Summary

A completed, prospective 6-month open-label study evaluating conversion from mycophenolate mofetil (MMF) to PRMYFORTIC in kidney transplant patients with late c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Complications

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• PRMYFORTIC (mycophenolic acid)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Late Complication From Kidney Transplant | Status: COMPLETED